Wow, investors are pouring money into HEPA today, it's up by 18.83 percent. The outlook is pretty good in terms of the future earning power of the company as well as the prospects for the industry.
The company isn't at an immediate support or resistance level that might be predictive. Hepion Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. HEPA might find some support at the 0.0347 level, buyers might push the price back up from here. But it's not very clear what will happen.
